A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH)

Elisa De Paolis, Angelo Minucci, Maria De Bonis, Giovanni Luca Scaglione, Jacopo Gervasoni, Aniello Primiano, Pietro Manuel Ferraro, Daniele Cappellani, Claudio Marcocci, Giovanni Gambaro, Ettore Capoluongo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: Loss-of-function mutations in cytochrome P450 family 24 subfamily A member 1 (CYP24A1) gene are associated with Idiopathic Infantile Hypercalcemia (IIH) and adult kidney stone disease. The enzyme deficiency leads to an impaired vitamin D catabolism pathway, resulting in a syndrome characterized by recurrent hypercalcemia, hypercalciuria and suppressed parathyroid hormone (PTH) levels. In these patients, the genetic evaluation of CYP24A1 is an important diagnostic tool, allowing the definitive diagnosis of IIH. Methods: A rapid CYP24A1 gene testing based on High Resolution Melting Analysis (HRMA) was designed in order to detect the CYP24A1 c.428_430delAAG (p.Glu143del), a recurrent IIH-associated variant. Results: HRMA method was able to identify c.428_430delAAG genotypes evaluating melting curve shape and melting temperature (Tm). Heterozygous samples exhibited a typical melting profile while homozygous samples showed a specific Tm shift. Conclusions: We provide evidence about application of HRMA in unambiguous genotyping of the CYP24A1 c.428_430delAAG variant, making this method useful in clinical molecular diagnostics. This approach opens the way to a helpful molecular analysis of CYP24A1 gene in IIH diagnosis, to an improved pharmacological treatment strategy and to a reduced risk of recurrent stones and worsening nephrocalcinosis.

Original languageEnglish
Pages (from-to)8-13
Number of pages6
JournalClinica Chimica Acta
Volume482
DOIs
Publication statusPublished - Jul 1 2018

Fingerprint

Cytochrome P-450 Enzyme System
Freezing
Screening
Melting
Testing
Genes
Nephrocalcinosis
Hypercalciuria
Temperature
Kidney Calculi
Molecular Pathology
Kidney Diseases
Hypercalcemia
Parathyroid Hormone
Vitamin D
Melting point
Infantile Hypercalcemia
Cytochrome P450 Family 24
Genotype
Pharmacology

Keywords

  • CYP24A1
  • High resolution melting analysis
  • Hypercalcemia
  • Hypercalciuria
  • Idiopathic Infantile Hypercalcemia
  • Vitamin D

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH). / De Paolis, Elisa; Minucci, Angelo; De Bonis, Maria; Scaglione, Giovanni Luca; Gervasoni, Jacopo; Primiano, Aniello; Ferraro, Pietro Manuel; Cappellani, Daniele; Marcocci, Claudio; Gambaro, Giovanni; Capoluongo, Ettore.

In: Clinica Chimica Acta, Vol. 482, 01.07.2018, p. 8-13.

Research output: Contribution to journalArticle

De Paolis, Elisa ; Minucci, Angelo ; De Bonis, Maria ; Scaglione, Giovanni Luca ; Gervasoni, Jacopo ; Primiano, Aniello ; Ferraro, Pietro Manuel ; Cappellani, Daniele ; Marcocci, Claudio ; Gambaro, Giovanni ; Capoluongo, Ettore. / A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH). In: Clinica Chimica Acta. 2018 ; Vol. 482. pp. 8-13.
@article{247dc9182b274a8e9dee1e40d2e88f04,
title = "A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH)",
abstract = "Introduction: Loss-of-function mutations in cytochrome P450 family 24 subfamily A member 1 (CYP24A1) gene are associated with Idiopathic Infantile Hypercalcemia (IIH) and adult kidney stone disease. The enzyme deficiency leads to an impaired vitamin D catabolism pathway, resulting in a syndrome characterized by recurrent hypercalcemia, hypercalciuria and suppressed parathyroid hormone (PTH) levels. In these patients, the genetic evaluation of CYP24A1 is an important diagnostic tool, allowing the definitive diagnosis of IIH. Methods: A rapid CYP24A1 gene testing based on High Resolution Melting Analysis (HRMA) was designed in order to detect the CYP24A1 c.428_430delAAG (p.Glu143del), a recurrent IIH-associated variant. Results: HRMA method was able to identify c.428_430delAAG genotypes evaluating melting curve shape and melting temperature (Tm). Heterozygous samples exhibited a typical melting profile while homozygous samples showed a specific Tm shift. Conclusions: We provide evidence about application of HRMA in unambiguous genotyping of the CYP24A1 c.428_430delAAG variant, making this method useful in clinical molecular diagnostics. This approach opens the way to a helpful molecular analysis of CYP24A1 gene in IIH diagnosis, to an improved pharmacological treatment strategy and to a reduced risk of recurrent stones and worsening nephrocalcinosis.",
keywords = "CYP24A1, High resolution melting analysis, Hypercalcemia, Hypercalciuria, Idiopathic Infantile Hypercalcemia, Vitamin D",
author = "{De Paolis}, Elisa and Angelo Minucci and {De Bonis}, Maria and Scaglione, {Giovanni Luca} and Jacopo Gervasoni and Aniello Primiano and Ferraro, {Pietro Manuel} and Daniele Cappellani and Claudio Marcocci and Giovanni Gambaro and Ettore Capoluongo",
year = "2018",
month = "7",
day = "1",
doi = "10.1016/j.cca.2018.03.024",
language = "English",
volume = "482",
pages = "8--13",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH)

AU - De Paolis, Elisa

AU - Minucci, Angelo

AU - De Bonis, Maria

AU - Scaglione, Giovanni Luca

AU - Gervasoni, Jacopo

AU - Primiano, Aniello

AU - Ferraro, Pietro Manuel

AU - Cappellani, Daniele

AU - Marcocci, Claudio

AU - Gambaro, Giovanni

AU - Capoluongo, Ettore

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Introduction: Loss-of-function mutations in cytochrome P450 family 24 subfamily A member 1 (CYP24A1) gene are associated with Idiopathic Infantile Hypercalcemia (IIH) and adult kidney stone disease. The enzyme deficiency leads to an impaired vitamin D catabolism pathway, resulting in a syndrome characterized by recurrent hypercalcemia, hypercalciuria and suppressed parathyroid hormone (PTH) levels. In these patients, the genetic evaluation of CYP24A1 is an important diagnostic tool, allowing the definitive diagnosis of IIH. Methods: A rapid CYP24A1 gene testing based on High Resolution Melting Analysis (HRMA) was designed in order to detect the CYP24A1 c.428_430delAAG (p.Glu143del), a recurrent IIH-associated variant. Results: HRMA method was able to identify c.428_430delAAG genotypes evaluating melting curve shape and melting temperature (Tm). Heterozygous samples exhibited a typical melting profile while homozygous samples showed a specific Tm shift. Conclusions: We provide evidence about application of HRMA in unambiguous genotyping of the CYP24A1 c.428_430delAAG variant, making this method useful in clinical molecular diagnostics. This approach opens the way to a helpful molecular analysis of CYP24A1 gene in IIH diagnosis, to an improved pharmacological treatment strategy and to a reduced risk of recurrent stones and worsening nephrocalcinosis.

AB - Introduction: Loss-of-function mutations in cytochrome P450 family 24 subfamily A member 1 (CYP24A1) gene are associated with Idiopathic Infantile Hypercalcemia (IIH) and adult kidney stone disease. The enzyme deficiency leads to an impaired vitamin D catabolism pathway, resulting in a syndrome characterized by recurrent hypercalcemia, hypercalciuria and suppressed parathyroid hormone (PTH) levels. In these patients, the genetic evaluation of CYP24A1 is an important diagnostic tool, allowing the definitive diagnosis of IIH. Methods: A rapid CYP24A1 gene testing based on High Resolution Melting Analysis (HRMA) was designed in order to detect the CYP24A1 c.428_430delAAG (p.Glu143del), a recurrent IIH-associated variant. Results: HRMA method was able to identify c.428_430delAAG genotypes evaluating melting curve shape and melting temperature (Tm). Heterozygous samples exhibited a typical melting profile while homozygous samples showed a specific Tm shift. Conclusions: We provide evidence about application of HRMA in unambiguous genotyping of the CYP24A1 c.428_430delAAG variant, making this method useful in clinical molecular diagnostics. This approach opens the way to a helpful molecular analysis of CYP24A1 gene in IIH diagnosis, to an improved pharmacological treatment strategy and to a reduced risk of recurrent stones and worsening nephrocalcinosis.

KW - CYP24A1

KW - High resolution melting analysis

KW - Hypercalcemia

KW - Hypercalciuria

KW - Idiopathic Infantile Hypercalcemia

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85044473116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044473116&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2018.03.024

DO - 10.1016/j.cca.2018.03.024

M3 - Article

VL - 482

SP - 8

EP - 13

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -